NCT04636775View on ClinicalTrials.gov

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

RecruitingOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

August 30, 2024

Study Completion Date

December 31, 2024

Conditions
NSCLC Stage IVNSCLC, Recurrent
Interventions
DIAGNOSTIC_TEST

Microbiome

Nasal and buccal swabs, and stool sample, as well as the extracted DNAs

Trial Locations (3)

66160

RECRUITING

The University of Kansas Medical Center, Kansas City

66205

RECRUITING

The University of Kansas Cancer Center (KUCC), Fairway

RECRUITING

The University of Kansas Cancer Center, Westwood Campus, Kansas City

All Listed Sponsors
lead

Jun Zhang, MD, PhD

OTHER